2014;38:1498–503. 3. Roayaie S, Jibara G, Taouli B, Schwartz M. Resection of hepatocel- lular carcinoma with macroscopic vascular invasion. Ann Surg Oncol. 2013;20:3754–60. 4. Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, et al. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition). Liver Cancer. 2020;9:682–720. 5. Liver EAFTSOT. EASL clinical practice guidelines: management of hepato - cellular carcinoma. J Hepatol. 2018;69:182–236. 6. Yarchoan M, Johnson BA III, Lutz ER, Laheru DA, Jaffee EM. Targeting neo - antigens to augment antitumour immunity. Nat Rev Cancer. 2017;17:209. 7. Wang T-Y, Wang L, Alam SK, Hoeppner LH, Yang R. ScanNeo: identify- ing indel-derived neoantigens using RNA-Seq data. Bioinformatics. 2019;35:4159–61. 8. Keskin DB, Anandappa AJ, Sun J, Tirosh I, Mathewson ND, Li S, et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature.